This summit brings together CIOs, CDOs, CISOs, CTOs, Heads of IT, and digital transformation leaders from India’s leading pharmaceutical, biotechnology, and life sciences organisations to shape the future of Pharmaceutical Technology.
Exito Media Concepts is set to host the 15th Edition Pharma IT Summit on 28 October 2026 at JW Marriott Juhu, Mumbai. The summit will bring together over 120 senior technology and business leaders from India’s leading pharmaceutical, biotechnology, and life sciences organisations under the theme
“Technology Decisions that Define Indian Pharma’s NextPhase,”
creating a strategic platform for industry leaders to explore the technologies redefining the future of the Pharmaceutical Industry.
India is widely recognised as the “Pharmacy of the World,” supplying nearly 20% of the world’s generic medicines and approximately 60% of global vaccine demand. India’s pharmaceutical industry is valued at USD 60.3 billion in FY 2025 – 26 and is projected to reach USD 130 billion by 2030, driven by digital transformation, biotechnology, innovation, and smart manufacturing.
As pharmaceutical organisations adopt AI, cloud, ERP modernisation, automation, analytics, and smart manufacturing, technology is becoming essential to resilience, compliance, quality, and growth.
At the same time, organisations must address cybersecurity risks across manufacturing environments, data privacy obligations, GxP requirements, and the growing complexity of global pharmaceutical operations.
India’s Pharma Industry is entering a defining era where technology must go hand in hand with resilience, trust, and regulatory excellence. The Pharma IT Summit 2026 will address these priorities through expert-led discussions, practical use cases, peer-to-peer conversations, and strategic networking. The summit will explore how pharmaceutical and life sciences organisations can adopt emerging technologies while maintaining data integrity, product quality, regulatory readiness, and business continuity.
Event Overview
The 15th Edition Pharma IT Summit is an event designed exclusively to connect India’s pharmaceutical technology leaders and accelerate digital transformation across the life sciences ecosystem. The summit will bring together senior decision-makers from pharmaceutical companies, biotechnology organisations, manufacturing organisations, digital health companies, technology providers, and related life sciences institutions.
The programme will focus on practical innovation and real-world transformation journeys across AI, ERP Modernisation, cloud, cybersecurity, digital manufacturing, regulatory technology, data governance, and automation. It will also provide opportunities for attendees to exchange experiences, evaluate emerging solutions, and build strategic partnerships.
Date: 28 October 2026
Time: 09:00 AM – 05:00 PM IST
Venue: JW Marriott Juhu
Format: By-invitation-only, in-person
Attendance: 120+ CIOs, CDOs, CISOs, CTOs, Heads of IT, and digital transformation leaders
Website: https://pharmaitsummit.com/
Confirmed Speakers
The summit will feature an exceptional lineup of industry leaders driving digital transformation
across India’s pharmaceutical ecosystem, including:
- Mandar Ghatnekar, Chief Technology Officer, Biocon
- Raj Kumar Patra, Vice President, Head of IT – Research and Discovery, Syngene International
- Pranav Gadre, Vice President – Head Information Technology, Reliance Life Sciences Pvt. Ltd.
- Mohit Agarwal, Commercial Excellence and IT Procurement / Digital Transformation,Wockhardt Ltd.
- Bijender Mishra, Global CISO & Senior GM, IT, Alkem Laboratories Ltd.
- Arif Poonawala, Founder & Managing Director – Unique Solutions
- Sairam Tanniru, Founder and CEO– Lowcode Labs
Strategic Agenda: Key Discussion Themes
The summit agenda addresses the most pressing technology priorities shaping India’s
Pharma landscape:
1.The Indian Pharma Technology Agenda for 2027-Five Decisions That Every CIO, CTO, and IT Leader Must Get Right
2.Deploying GenAI in a GxP-Regulated IT Environment- Platform Architecture, Governance, and the Shadow AI Problem
3.ERP Modernization in Indian Pharma – The GxP Compliance Questions That Shape the Migration Strategy
4.India’s DPDP Act Phase II Goes Live in November 2026
5.Securing India’s Pharma Manufacturing Plants-OT/IT Convergence, Nation-State Threats, and the Reality of Plant Floor Cyber Risk
6.From CSV to CSA- How Indian Pharma IT Teams Must Rethink Computer System Validation
7.Cloud Architecture for Indian Pharma IT- Making the Hybrid Cloud, GxP Validation, and DPDP Compliance Decisions That Define Your Infrastructure for the Next Decade
About Exito Media Concepts
Exito – meaning “success”- is a globally recognised B2B events and media organisation with over 16 years of expertise. Delivering more than 240 conferences annually across technology, digital transformation, cybersecurity, healthcare, manufacturing, financial services, and emerging enterprise sectors, Exito creates platforms that foster strategic collaboration, accelerate innovation adoption, and drive measurable business outcomes. The Pharma IT Summit is part of Exito’s flagship global event series hosted across multiple international markets.
For more details, visit: https://pharmaitsummit.com/
Media Contact
Ankita Ghosh
Media & PR Executive, Exito Media Concepts Pvt. Ltd.
Email: [email protected]
Phone: +91 9910943411
Website: https://www.exito-e.com/
Disclaimer
For paid/sponsored articles, FintechMode neither endorses nor takes responsibility for the accuracy, timeliness, quality, and content of said articles. The statements, views and opinions expressed in paid/sponsored articles are solely those of the content provider and readers are reminded that Cryptocurrency products are unregulated in most locations and can be highly risky. Do your own research and consult relevant financial experts before making any investment decisions. FintechMode will not be held accountable, either directly or indirectly, for any harm or loss that may stem from or be linked to the usage or reliance on any information, goods, or services mentioned on this page. If you have any concerns, please email [email protected] or refer to our Terms & Conditions
